{"nct_id":"NCT04029116","title":"Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC)","status":"COMPLETED","status_verified_date":"2023-05","start_date":"2019-10-21","start_date_type":"ACTUAL","primary_completion_date":"2021-09-01","primary_completion_date_type":"ACTUAL","completion_date":"2021-11-29","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SCYX"]}